About
Craig Mallinckrodt is a senior biostatistician and clinical-trials methodology expert in biopharma. He is currently a Distinguished Biostatistician at Pentara, after earlier roles at Eli Lilly and Biogen, and is known for work on missing data, estimands, longitudinal trial analysis, and clinical development optimization. His public profile is that of a scientific and statistical influencer in drug development rather than a capital deployer.
Areas of interest
biostatisticsclinical trialsdrug developmentAlzheimer's diseaseneurodegenerative diseasepharmaceutical R&Dmissing data methodologyestimandssensitivity analysisportfolio analytics